Vitamin D and the risk of uterine fibroids

Epidemiology

Volumn 24, Issue 3, 2013, Pages 447-453

  Baird, Donna Day ^a   Hill, Michael C ^b   Schectman, Joel M ^c   Hollis, Bruce W ^d  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; VITAMIN D;

ABDOMINAL RADIOGRAPHY; ADULT; ARTICLE; CAUCASIAN; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NEGRO; PREMENOPAUSE; PRIORITY JOURNAL; QUESTIONNAIRE; RADIOIMMUNOASSAY; RISK FACTOR; SCREENING; SELF REPORT; SUN EXPOSURE; TRANSVAGINAL ECHOGRAPHY; UTERUS MYOMA; VITAMIN D DEFICIENCY;

ADULT; AFRICAN AMERICANS; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; DISTRICT OF COLUMBIA; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; LEIOMYOMA; LINEAR MODELS; LOGISTIC MODELS; MIDDLE AGED; QUESTIONNAIRES; RISK FACTORS; SUNLIGHT; UTERINE NEOPLASMS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84876290071     PISSN: 10443983     EISSN: 15315487     Source Type: Journal    
DOI: 10.1097/EDE.0b013e31828acca0     Document Type: Article

References (45)

1. Stewart EA. Uterine fbroids. Lancet. 2001;357:293-298.
2. Schwartz SM, Marshall LM. Uterine leiomyomata. in: Goldman MB, Hatch MC, Eds. Women and Health. San Diego, CA: Academic Press; 2000:240-252.
3. Schwartz SM, Marshall LM, Baird DD. Epidemiologic contributions to understanding the etiology of uterine leiomyomata. Environ Health Per-spect. 2000;108(suppl 5):821-827.
4. Farquhar CM, Steiner CA. Hysterectomy rates in the United States 1990-1997. Obstet Gynecol. 2002;99:229-234.
5. Cardozo ER, Clark AD, Banks NK, Henne MB, Stegmann BJ, Segars JH. The estimated annual cost of uterine leiomyomata in the United States. Am J Obstet Gynecol. 2012;206:211.e1-211.e9.
6. Laughlin SK, Baird DD, Savitz DA, Herring AH, Hartmann KE. Prevalence of uterine leiomyomas in the frst trimester of pregnancy: an ultrasound-screening study. Obstet Gynecol. 2009;113:630-635.
7. Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188:100-107.
8. Kjerulff KH, Langenberg P, Seidman JD, Stolley PD, Guzinski GM. Uterine leiomyomas. racial differences in severity, symptoms and age at diagnosis. J Reprod Med. 1996;41:483-490.
9. Myers ER, Barber M W, Couchman GM, et al. Management of Uterine Fibroids (evidence report/technology assessment NO. 34, contract 290-97-0014 to the Duke evidence-based Practice center). AHRQ Publication NO. 01-e052. Rockville, MD: agency for Healthcare research and Quality; 2001.
10. Makariou S, Liberopoulos EN, Elisaf M, Challa A. Novel roles of vitamin D in disease: what is new in 2011? Eur J Intern Med. 2011;22:355-362.
11. Holick M F. Vitamin D defciency. N Engl J Med. 2007;357:266-281.
12. Fleet JC, DeSmet M, Johnson R, Li Y. Vitamin D and cancer: a review of molecular mechanisms. Biochem J. 2012;441:61-76.
13. Leppert PC, Catherino WH, Segars JH. A new hypothesis about the origin of uterine fbroids based on gene expression profling with microarrays. Am J Obstet Gynecol. 2006;195:415-420.
14. Sabry M, Al-Hendy A. Innovative oral treatments of uterine leiomyoma. Obstet Gynecol Int. 2012;2012:943635.
15. Zhao G, Ford ES, Tsai J, Li C, Croft JB. Factors associated with vitamin D defciency and inadequacy among women of childbearing age in the United States. ISRN Obstet Gynecol. 2012;2012:691486.
16. Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. Association of physical activity with development of uterine leiomyoma. Am J Epidemiol. 2007;165:157-163.
17. Hollis B W. Editorial: the determination of circulating 25-hydroxyvitamin D: no easy task. J Clin Endocrinol Metab. 2004;89:3149-3151.
18. Hollis B W, Kamerud JQ, Selvaag SR, Lorenz JD, Napoli JL. Determination of vitamin D status by radioimmunoassay with an 125i-labeled tracer. Clin Chem. 1993;39:529-533.
19. Baird DD, Dunson DB. Why is parity protective for uterine fbroids? Epidemiology. 2003;14:247-250.
20. th Workshop consensus for vitamin D nutritional guidelines. J Steroid Biochem Mol Biol. 2007;103:204-205.
21. Haussler MR, Jurutka P W, Mizwicki M, Norman AW. Vitamin D receptor (VDr)-mediated actions of 1alpha, 25(OH)(2)vitamin D(3): genomic and non-genomic mechanisms. Best Pract Res Clin Endocrinol Metab. 2011;25:543-559.
22. Pilz S, Tomaschitz A, März W, et al. Vitamin D, Cardiovascular disease and mortality. Clin Endocrinol (Oxf). 2011;75:575-584.
23. Giovannucci E. Vitamin D and cancer incidence in the Harvard cohorts. Ann Epidemiol. 2009;19:84-88.
24. Holick MF. Vitamin D: extraskeletal health. Endocrinol Metab Clin North AM. 2010;39:381-400, table of contents.
25. Halder SK, Sharan C, Al-Hendy A. 1, 25-dihydroxyvitamin D3 treatment shrinks uterine leiomyoma tumors in the eker rat model. Biol Reprod. 2012;86:116.
26. Bläuer M, Rovio PH, Ylikomi T, Heinonen PK. Vitamin D inhibits myometrial and leiomyoma cell proliferation in vitro. Fertil Steril. 2009;91:1919-1925.
27. Sharan C, Halder SK, Thota C, Jaleel T, Nair S, Al-Hendy A. Vitamin D inhibits proliferation of human uterine leiomyoma cells via catechol-O- methyltransferase. Fertil Steril. 2011;95:247-253.
28. Halder SK, Goodwin JS, Al-Hendy A. 1, 25-Dihydroxyvitamin D3 reduces tgF-beta3-induced fbrosis-related gene expression in human uterine leiomyoma cells. J Clin Endocrinol Metab. 2011;96:e754-e762.
29. Zittermann A, Schleithoff SS, Koerfer R. Putting cardiovascular disease and vitamin D insuffciency into perspective. Br J Nutr. 2005;94:483-492.
30. Song Y, Qi H, Wu C. Effect of 1, 25-(OH)2D3 (a vitamin D analogue) on passively sensitized human airway smooth muscle cells. Respirology. 2007;12:486-494.
31. Tan X, Li Y, Liu Y. Therapeutic role and potential mechanisms of active Vitamin D in renal interstitial fbrosis. J Steroid Biochem Mol Biol. 2007;103:491-496.
32. Cross HS, Kallay E. Regulation of the colonic vitamin D system for prevention of tumor progression: an update. Future Oncol. 2009;5:493-507.
33. Friedrich M, Raf L, Mitschele T, Tilgen W, Schmidt W, Reichrath J. Analysis of the vitamin D system in cervical carcinomas, breast cancer and ovarian cancer. Recent Results Cancer Res. 2003;164:239-246.
34. Becker S, Cordes T, Diesing D, Diedrich K, Friedrich M. Expression of 25 hydroxyvitamin D3-1alpha-hydroxylase in human endometrial tissue. J Steroid Biochem Mol Biol. 2007;103:771-775.
35. Zehnder D, Evans KN, Kilby MD, et al. The ontogeny of 25-hydroxyvita-min D(3) 1alpha-hydroxylase expression in human placenta and decidua. Am J Pathol. 2002;161:105-114.
36. Coney P, Demers LM, Dodson WC, Kunselman AR, Ladson G, Legro RS. Determination of vitamin D in relation to body mass index and race in a defned population of black and white women. Int J Gynaecol Obstet. 2012;119:21-25.
37. Jones G. Pharmacokinetics of vitamin D toxicity. Am J Clin Nutr. 2008;88:582S-586S.
38. Jorde R, Sneve M, Hutchinson M, Emaus N, Figenschau Y, Grimnes G. Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 12 months in an intervention study. Am J Epidemiol. 2010;171:903-908.
39. Kluczynski MA, Wactawski-Wende J, Platek ME, Denysschen CA, Hovey KM, Millen AE. Changes in vitamin D supplement use and baseline plasma 25-hydroxyvitamin D concentration predict 5-y change in concentration in postmenopausal women. J Nutr. 2012;142:1705-1712.
40. Meng JE, Hovey KM, Wactawski-Wende J, et al. Intraindividual variation in plasma 25-hydroxyvitamin D measures 5 years apart among postmeno-pausal women. Cancer Epidemiol Biomarkers Prev. 2012;21:916-924.
41. Saliba W, Barnett O, Stein N, Kershenbaum A, Rennert G. The longitudinal variability of serum 25(OH)D levels. Eur J Intern Med. 2012;23:e106-e111.
42. Sonderman JS, Munro HM, Blot WJ, Signorello LB. Reproducibility of serum 25-hydroxyvitamin d and vitamin D-binding protein levels over time in a prospective cohort study of black and white adults. Am J Epidemiol. 2012;176:615-621.
43. Kant AK, Graubard BI. Ethnic and socioeconomic differences in variability in nutritional biomarkers. Am J Clin Nutr. 2008;87:1464-1471.
44. Van der Mei IA, Blizzard L, Ponsonby AL, Dwyer T. Validity and reliability of adult recall of past sun exposure in a case-control study of multiple sclerosis. Cancer Epidemiol Biomarkers Prev. 2006;15: 1538-1544.
45. Mccarty CA. Sunlight exposure assessment: can we accurately assess vitamin D exposure from sunlight questionnaires? Am J Clin Nutr. 2008;87:1097S-1101S.